Evidence map›Paper›PMID 26388239›Full record

ArticleCellular & molecular immunology2017

Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion.

Bei-Ping Miao, Rui-Shi Zhang, Huan-Ji Sun, Yan-Ping Yu, Tao Chen, Lin-Jing Li, Jiang-Qi Liu, Jun Liu, Hai-Qiong Yu, Min Zhang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Gut microbiota shapes cancer immunotherapy responses.NPJ biofilms and microbiomes · 2025
    Review
  3. Review
  4. Review
  5. The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Targeting the IL-9 pathway in cancer immunotherapy.Human vaccines & immunotherapeutics · 2020
    Review
  11. Th9 cells in allergic diseases: A role for the microbiota?Scandinavian journal of immunology · 2020
    Review
  12. IL-9 and IL-9-producing cells in tumor immunity.Cell communication and signaling : CCS · 2020
    Review
  13. Review
  14. Article
  15. [Expression of interleukin-9 in colon cancer tissues and its clinical significance].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  16. TSeminars in immunopathology · 2017
    Review
  17. Human Vδ2 T cells are a major source of interleukin-9.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Bei-Ping MiaoDepartment of Otolaryngology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Rui-Shi ZhangDepartment of Otolaryngology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Huan-Ji SunDepartment of Otolaryngology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Yan-Ping YuDepartment of Otolaryngology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Tao ChenDepartment of Otolaryngology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Lin-Jing LiBrain Body Institute, McMaster University, Hamilton, ON L8N 4A6, Canada.
Jiang-Qi LiuBrain Body Institute, McMaster University, Hamilton, ON L8N 4A6, Canada.
Jun LiuShenzhen Women & Children Healthcare, Shenzhen, China.
Hai-Qiong YuCenter of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Min ZhangDepartment of Respirology, the First Affiliated Hospital of Shenzhen University and the Second People's Hospital of Shenzhen, Shenzhen, China.
Zhi-Gang LiuCenter of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Ping-Chang YangCenter of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Shenzhen Second People's Hospital · CNShenzhen University · CNShenzhen Maternity and Child Healthcare Hospital · CNMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, therapy for squamous cancer (SqC) is unsatisfactory. Staphylococcal enterotoxin B (SEB) has strong immune regulatory activity. This study tests the hypothesis that SEB enforces the effect of immunotherapy on SqC growth in a mouse model. C3H/HeN mice and the SqC cell line squamous cell carcinoma VII were used to create an SqC mouse model. Immune cell assessment was performed by flow cytometry. Real-time RT-PCR and western blotting were used to evaluate target molecule expression. An apoptosis assay was used to assess the suppressive effect of T helper-9 (Th9) cells on the SqC cells. The results showed that immunotherapy consisting of SEB plus SqC antigen significantly inhibited SqC growth in the mice. The frequency of Th9 cells was markedly increased in the SqC tissue and mouse spleens after treatment. SEB markedly increased the levels of signal transducer and activator of transcription 5 phosphorylation and the expression of histone deacetylase-1 (HDAC1) and PU.1 (the transcription factor of the interleukin 9 (IL-9) gene) in CD4

Indexed as

AnimalsAntigens, NeoplasmApoptosisCell Line, TumorCell ProliferationDisease Models, AnimalEnterotoxinsFemaleInterleukin-9MiceNeoplasms, Squamous CellT-Lymphocytes, Helper-InducerTumor BurdenAntigens, Neoplasmenterotoxin B, staphylococcalEnterotoxinsInterleukin-9

Identifiers

PMID26388239
PMCPMC5380942
OpenAlexW2343893858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.